Atara Biotherapeutics Appoints Eric Hyllengren As Chief Operating Officer In Addition To His Role As Chief Financial Officer
Portfolio Pulse from Benzinga Newsdesk
Atara Biotherapeutics has appointed Eric Hyllengren as Chief Operating Officer, in addition to his role as Chief Financial Officer. His base salary has been increased to $520,000 annually. There are no related person transactions or arrangements involved in this promotion.
October 15, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Atara Biotherapeutics has expanded Eric Hyllengren's role to include Chief Operating Officer, alongside his CFO duties, with a salary increase to $520,000. This leadership change is not associated with any related person transactions.
The appointment of Eric Hyllengren as COO, in addition to his CFO role, indicates a strategic leadership decision by Atara Biotherapeutics. The salary increase reflects the added responsibilities. However, as there are no related person transactions or arrangements, the immediate financial impact on the company is neutral.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80